메뉴 건너뛰기




Volumn 113, Issue 7, 2016, Pages E839-E846

Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase

Author keywords

Antibiotic resistance; Complex stability; Fluoroquinolones; Gyrase; Mycobacterium tuberculosis

Indexed keywords

ALANINE; BACTERIAL ENZYME; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; MOXIFLOXACIN; MYCOBACTERIUM TUBERCULOSIS GYRASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); METAL; QUINOLONE DERIVATIVE; WATER;

EID: 84959386892     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1525055113     Document Type: Article
Times cited : (69)

References (51)
  • 1
    • 84959398599 scopus 로고    scopus 로고
    • Tuberculosis
    • Accessed July 21, 2014
    • World Health Organization (2014) Tuberculosis. Fact Sheet No 104. www.who.int/ mediacentre/factsheets/fs104/en/. Accessed July 21, 2014.
    • (2014) Fact Sheet , vol.104
  • 4
    • 84901039783 scopus 로고    scopus 로고
    • Treatment of tuberculosis
    • American Thoracic Society; CDC; Infectious Diseases Society of America (RR-11): 1-77, and erratum (2005)
    • American Thoracic Society; CDC; Infectious Diseases Society of America (2003) Treatment of tuberculosis. MMWR Recomm Rep 52(RR-11): 1-77, and erratum (2005) 53: 1203.
    • (2003) MMWR Recomm Rep , vol.52 , Issue.53 , pp. 1203
  • 6
    • 84959398600 scopus 로고    scopus 로고
    • TB Alliance Interactive Portfolio Available at ccessed November 24 2015
    • TB Alliance Interactive Portfolio (2015) PaMZ. Available at www.tballiance.org/portfolio/ regimen/pamz. Accessed November 24, 2015.
    • (2015) PaMZ.
  • 7
    • 0032189757 scopus 로고    scopus 로고
    • Clinical applications of quinolones
    • Hooper DC (1998) Clinical applications of quinolones. BiochimBiophys Acta 1400(1-3): 45-61.
    • (1998) BiochimBiophys Acta , vol.1400 , Issue.1-3 , pp. 45-61
    • Hooper, D.C.1
  • 8
    • 0035866965 scopus 로고    scopus 로고
    • Mechanisms of action of antimicrobials: Focus on fluoroquinolones
    • Hooper DC (2001) Mechanisms of action of antimicrobials: Focus on fluoroquinolones. Clin Infect Dis 32(Suppl 1): S9-S15.
    • (2001) Clin Infect Dis , vol.32 , pp. S9-S15
    • Hooper, D.C.1
  • 9
    • 21844443566 scopus 로고    scopus 로고
    • The quinolones: Past, present, and future
    • Andriole VT (2005) The quinolones: Past, present, and future. Clin Infect Dis 41(suppl 2): S113-S119.
    • (2005) Clin Infect Dis , vol.41 , pp. S113-S119
    • Andriole, V.T.1
  • 10
    • 74049088254 scopus 로고    scopus 로고
    • Quinolones: Action and resistance updated
    • Drlica K, et al. (2009) Quinolones: Action and resistance updated. Curr Top Med Chem 9(11): 981-998.
    • (2009) Curr Top Med Chem , vol.9 , Issue.11 , pp. 981-998
    • Drlica, K.1
  • 11
    • 77954187741 scopus 로고    scopus 로고
    • DNA topoisomerases and their poisoning by anticancer and antibacterial drugs
    • Pommier Y, Leo E, Zhang H, Marchand C (2010) DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. Chem Biol 17(5): 421-433.
    • (2010) Chem Biol , vol.17 , Issue.5 , pp. 421-433
    • Pommier, Y.1    Leo, E.2    Zhang, H.3    Marchand, C.4
  • 12
    • 84898948830 scopus 로고    scopus 로고
    • Mechanism of quinolone action and resistance
    • Aldred KJ, Kerns RJ, Osheroff N (2014) Mechanism of quinolone action and resistance. Biochemistry 53(10): 1565-1574.
    • (2014) Biochemistry , vol.53 , Issue.10 , pp. 1565-1574
    • Aldred, K.J.1    Kerns, R.J.2    Osheroff, N.3
  • 13
    • 0035042602 scopus 로고    scopus 로고
    • Type II topoisomerases as targets for quinolone antibacterials: Turning Dr. Jekyll into Mr. Hyde
    • Anderson VE, Osheroff N (2001) Type II topoisomerases as targets for quinolone antibacterials: Turning Dr. Jekyll into Mr. Hyde. Curr Pharm Des 7(5): 337-353.
    • (2001) Curr Pharm Des , vol.7 , Issue.5 , pp. 337-353
    • Anderson, V.E.1    Osheroff, N.2
  • 15
    • 0032189275 scopus 로고    scopus 로고
    • DNA gyrase and topoisomerase IV: Biochemical activities, physiological roles during chromosome replication, and drug sensitivities
    • Levine C, Hiasa H, Marians KJ (1998) DNA gyrase and topoisomerase IV: Biochemical activities, physiological roles during chromosome replication, and drug sensitivities. Biochim Biophys Acta 1400(1-3): 29-43.
    • (1998) Biochim Biophys Acta , vol.1400 , Issue.1-3 , pp. 29-43
    • Levine, C.1    Hiasa, H.2    Marians, K.J.3
  • 16
    • 0034923502 scopus 로고    scopus 로고
    • DNA topoisomerases: Structure, function, and mechanism
    • Champoux JJ (2001) DNA topoisomerases: Structure, function, and mechanism. Annu Rev Biochem 70: 369-413.
    • (2001) Annu Rev Biochem , vol.70 , pp. 369-413
    • Champoux, J.J.1
  • 17
    • 0032508046 scopus 로고    scopus 로고
    • Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
    • Cole ST, et al. (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393(6685): 537-544.
    • (1998) Nature , vol.393 , Issue.6685 , pp. 537-544
    • Cole, S.T.1
  • 18
    • 33746819774 scopus 로고    scopus 로고
    • First functional characterization of a singly expressed bacterial type II topoisomerase: The enzyme from Mycobacterium tuberculosis
    • Aubry A, Fisher LM, Jarlier V, Cambau E (2006) First functional characterization of a singly expressed bacterial type II topoisomerase: The enzyme from Mycobacterium tuberculosis. Biochem Biophys Res Commun 348(1): 158-165.
    • (2006) Biochem Biophys Res Commun , vol.348 , Issue.1 , pp. 158-165
    • Aubry, A.1    Fisher, L.M.2    Jarlier, V.3    Cambau, E.4
  • 19
    • 77956343814 scopus 로고    scopus 로고
    • Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance
    • Wohlkonig A, et al. (2010) Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance. Nat Struct Mol Biol 17(9): 1152-1153.
    • (2010) Nat Struct Mol Biol , vol.17 , Issue.9 , pp. 1152-1153
    • Wohlkonig, A.1
  • 20
    • 84863030593 scopus 로고    scopus 로고
    • Drug interactions with Bacillus anthracis topoisomerase IV: Biochemical basis for quinolone action and resistance
    • Aldred KJ, et al. (2012) Drug interactions with Bacillus anthracis topoisomerase IV: Biochemical basis for quinolone action and resistance. Biochemistry 51(1): 370-381.
    • (2012) Biochemistry , vol.51 , Issue.1 , pp. 370-381
    • Aldred, K.J.1
  • 21
    • 84877257450 scopus 로고    scopus 로고
    • Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: Mechanistic basis of quinolone resistance
    • Aldred KJ, McPherson SA, Turnbough CL, Jr, Kerns RJ, Osheroff N (2013) Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: Mechanistic basis of quinolone resistance. Nucleic Acids Res 41(8): 4628-4639.
    • (2013) Nucleic Acids Res , vol.41 , Issue.8 , pp. 4628-4639
    • Aldred, K.J.1    McPherson, S.A.2    Turnbough, C.L.3    Kerns, R.J.4    Osheroff, N.5
  • 22
    • 0031407768 scopus 로고    scopus 로고
    • DNA gyrase, topoisomerase IV, and the 4-quinolones
    • Drlica K, Zhao X (1997) DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 61(3): 377-392.
    • (1997) Microbiol Mol Biol Rev , vol.61 , Issue.3 , pp. 377-392
    • Drlica, K.1    Zhao, X.2
  • 23
    • 0031728829 scopus 로고    scopus 로고
    • Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV in quinolone-resistant clinical isolates of Staphylococcus epidermidis
    • Li Z, et al. (1998) Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV in quinolone-resistant clinical isolates of Staphylococcus epidermidis. Antimicrob Agents Chemother 42(12): 3293-3295.
    • (1998) Antimicrob Agents Chemother , vol.42 , Issue.12 , pp. 3293-3295
    • Li, Z.1
  • 24
    • 0032705719 scopus 로고    scopus 로고
    • Mode of action of fluoroquinolones
    • Hooper DC (1999) Mode of action of fluoroquinolones. Drugs 58(suppl 2): 6-10.
    • (1999) Drugs , vol.58 , pp. 6-10
    • Hooper, D.C.1
  • 25
    • 0038650918 scopus 로고    scopus 로고
    • In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin
    • Price LB, et al. (2003) In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin. Antimicrob Agents Chemother 47(7): 2362-2365.
    • (2003) Antimicrob Agents Chemother , vol.47 , Issue.7 , pp. 2362-2365
    • Price, L.B.1
  • 27
    • 79951956663 scopus 로고    scopus 로고
    • Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates
    • Bansal S, Tandon V (2011) Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates. Int J Antimicrob Agents 37(3): 253-255.
    • (2011) Int J Antimicrob Agents , vol.37 , Issue.3 , pp. 253-255
    • Bansal, S.1    Tandon, V.2
  • 28
    • 84858665539 scopus 로고    scopus 로고
    • A systematic review of gyrase mutations associated with fluoroquinolone- resistant Mycobacterium tuberculosis and a proposed gyrase numbering system
    • Maruri F, et al. (2012) A systematic review of gyrase mutations associated with fluoroquinolone- resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. J Antimicrob Chemother 67(4): 819-831.
    • (2012) J Antimicrob Chemother , vol.67 , Issue.4 , pp. 819-831
    • Maruri, F.1
  • 29
    • 84891557923 scopus 로고    scopus 로고
    • Community-acquired pneumonia and tuberculosis: Differential diagnosis and the use of fluoroquinolones
    • Grossman RF, Hsueh PR, Gillespie SH, Blasi F (2014) Community-acquired pneumonia and tuberculosis: Differential diagnosis and the use of fluoroquinolones. Int J Infect Dis 18: 14-21.
    • (2014) Int J Infect Dis , vol.18 , pp. 14-21
    • Grossman, R.F.1    Hsueh, P.R.2    Gillespie, S.H.3    Blasi, F.4
  • 30
    • 65549120186 scopus 로고    scopus 로고
    • Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis
    • Long R, et al. (2009) Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis. Clin Infect Dis 48(10): 1354-1360.
    • (2009) Clin Infect Dis , vol.48 , Issue.10 , pp. 1354-1360
    • Long, R.1
  • 31
    • 68849086908 scopus 로고    scopus 로고
    • Fluoroquinolone resistance in Mycobacterium tuberculosis: The effect of duration and timing of fluoroquinolone exposure
    • Devasia RA, et al. (2009) Fluoroquinolone resistance in Mycobacterium tuberculosis: The effect of duration and timing of fluoroquinolone exposure. Am J Respir Crit Care Med 180(4): 365-370.
    • (2009) Am J Respir Crit Care Med , vol.180 , Issue.4 , pp. 365-370
    • Devasia, R.A.1
  • 32
    • 84890834354 scopus 로고    scopus 로고
    • Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions
    • Aldred KJ, et al. (2013) Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions. ACS Chem Biol 8(12): 2660-2668.
    • (2013) ACS Chem Biol , vol.8 , Issue.12 , pp. 2660-2668
    • Aldred, K.J.1
  • 33
    • 84906877854 scopus 로고    scopus 로고
    • Role of the water-metal ion bridge in mediating interactions between quinolones and Escherichia coli topoisomerase IV
    • Aldred KJ, et al. (2014) Role of the water-metal ion bridge in mediating interactions between quinolones and Escherichia coli topoisomerase IV. Biochemistry 53(34): 5558-5567.
    • (2014) Biochemistry , vol.53 , Issue.34 , pp. 5558-5567
    • Aldred, K.J.1
  • 34
    • 84959422266 scopus 로고    scopus 로고
    • Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis
    • Blower TR, Williamson BH, Kerns RJ, Berger JM (2016) Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis. Proc Natl Acad Sci USA 113: 1706-1713.
    • (2016) Proc Natl Acad Sci USA , vol.113 , pp. 1706-1713
    • Blower, T.R.1    Williamson, B.H.2    Kerns, R.J.3    Berger, J.M.4
  • 35
    • 0036774642 scopus 로고    scopus 로고
    • Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv
    • Camus JC, Pryor MJ, Médigue C, Cole ST (2002) Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology 148(pt 10): 2967-2973.
    • (2002) Microbiology , vol.148 , pp. 2967-2973
    • Camus, J.C.1    Pryor, M.J.2    Médigue, C.3    Cole, S.T.4
  • 36
    • 0029909110 scopus 로고    scopus 로고
    • Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrugresistant Mycobacterium tuberculosis
    • Xu C, Kreiswirth BN, Sreevatsan S, Musser JM, Drlica K (1996) Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrugresistant Mycobacterium tuberculosis. J Infect Dis 174(5): 1127-1130.
    • (1996) J Infect Dis , vol.174 , Issue.5 , pp. 1127-1130
    • Xu, C.1    Kreiswirth, B.N.2    Sreevatsan, S.3    Musser, J.M.4    Drlica, K.5
  • 37
    • 29944444255 scopus 로고    scopus 로고
    • Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: Functional analysis of mutant enzymes
    • Aubry A, et al. (2006) Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: Functional analysis of mutant enzymes. Antimicrob Agents Chemother 50(1): 104-112.
    • (2006) Antimicrob Agents Chemother , vol.50 , Issue.1 , pp. 104-112
    • Aubry, A.1
  • 38
    • 33846897468 scopus 로고    scopus 로고
    • Structure-activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors
    • Tran TP, et al. (2007) Structure-activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors. Bioorg Med Chem Lett 17(5): 1312-1320.
    • (2007) Bioorg Med Chem Lett , vol.17 , Issue.5 , pp. 1312-1320
    • Tran, T.P.1
  • 39
    • 55849113010 scopus 로고    scopus 로고
    • Use of gyrase resistance mutants to guide selection of 8-methoxy-quinazoline-2,4-diones
    • German N, Malik M, Rosen JD, Drlica K, Kerns RJ (2008) Use of gyrase resistance mutants to guide selection of 8-methoxy-quinazoline-2,4-diones. Antimicrob Agents Chemother 52(11): 3915-3921.
    • (2008) Antimicrob Agents Chemother , vol.52 , Issue.11 , pp. 3915-3921
    • German, N.1    Malik, M.2    Rosen, J.D.3    Drlica, K.4    Kerns, R.J.5
  • 40
    • 70349126269 scopus 로고    scopus 로고
    • Probing the differential interactions of quinazolinedione PD 0305970 and quinolones with gyrase and topoisomerase IV
    • Pan XS, Gould KA, Fisher LM (2009) Probing the differential interactions of quinazolinedione PD 0305970 and quinolones with gyrase and topoisomerase IV. Antimicrob Agents Chemother 53(9): 3822-3831.
    • (2009) Antimicrob Agents Chemother , vol.53 , Issue.9 , pp. 3822-3831
    • Pan, X.S.1    Gould, K.A.2    Fisher, L.M.3
  • 41
    • 77953780481 scopus 로고    scopus 로고
    • Comparison of in vitro activities of fluoroquinolone-like 2,4- and 1,3-diones
    • Oppegard LM, et al. (2010) Comparison of in vitro activities of fluoroquinolone-like 2,4- and 1,3-diones. Antimicrob Agents Chemother 54(7): 3011-3014.
    • (2010) Antimicrob Agents Chemother , vol.54 , Issue.7 , pp. 3011-3014
    • Oppegard, L.M.1
  • 42
    • 79955546959 scopus 로고    scopus 로고
    • Fluoroquinolone and quinazolinedione activities against wildtype and gyrase mutant strains of Mycobacterium smegmatis
    • Malik M, et al. (2011) Fluoroquinolone and quinazolinedione activities against wildtype and gyrase mutant strains of Mycobacterium smegmatis. Antimicrob Agents Chemother 55(5): 2335-2343.
    • (2011) Antimicrob Agents Chemother , vol.55 , Issue.5 , pp. 2335-2343
    • Malik, M.1
  • 43
    • 0031753298 scopus 로고    scopus 로고
    • Fluoroquinolone action against mycobacteria: Effects of C-8 substituents on growth, survival, and resistance
    • Dong Y, Xu C, Zhao X, Domagala J, Drlica K (1998) Fluoroquinolone action against mycobacteria: Effects of C-8 substituents on growth, survival, and resistance. Antimicrob Agents Chemother 42(11): 2978-2984.
    • (1998) Antimicrob Agents Chemother , vol.42 , Issue.11 , pp. 2978-2984
    • Dong, Y.1    Xu, C.2    Zhao, X.3    Domagala, J.4    Drlica, K.5
  • 44
    • 0033011810 scopus 로고    scopus 로고
    • Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: Effects of a C-8methoxyl group on survival in liquid media and in human macrophages
    • Zhao BY, Pine R, Domagala J, Drlica K (1999) Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: Effects of a C-8methoxyl group on survival in liquid media and in human macrophages. Antimicrob Agents Chemother 43(3): 661-666.
    • (1999) Antimicrob Agents Chemother , vol.43 , Issue.3 , pp. 661-666
    • Zhao, B.Y.1    Pine, R.2    Domagala, J.3    Drlica, K.4
  • 45
    • 0032168167 scopus 로고    scopus 로고
    • Etoposide: Four decades of development of a topoisomerase II inhibitor
    • Hande KR (1998) Etoposide: Four decades of development of a topoisomerase II inhibitor. Eur J Cancer 34(10): 1514-1521.
    • (1998) Eur J Cancer , vol.34 , Issue.10 , pp. 1514-1521
    • Hande, K.R.1
  • 47
    • 84896931441 scopus 로고    scopus 로고
    • Molecular basis for the differential quinolone susceptibility of mycobacterial DNA gyrase
    • Kumar R, Madhumathi BS, Nagaraja V (2014) Molecular basis for the differential quinolone susceptibility of mycobacterial DNA gyrase. Antimicrob Agents Chemother 58(4): 2013-2020.
    • (2014) Antimicrob Agents Chemother , vol.58 , Issue.4 , pp. 2013-2020
    • Kumar, R.1    Madhumathi, B.S.2    Nagaraja, V.3
  • 48
    • 0030958484 scopus 로고    scopus 로고
    • Spontaneous DNA lesions poison human topoisomerase IIa and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints
    • Kingma PS, Greider CA, Osheroff N (1997) Spontaneous DNA lesions poison human topoisomerase IIa and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints. Biochemistry 36(20): 5934-5939.
    • (1997) Biochemistry , vol.36 , Issue.20 , pp. 5934-5939
    • Kingma, P.S.1    Greider, C.A.2    Osheroff, N.3
  • 49
    • 0033598702 scopus 로고    scopus 로고
    • DNA topoisomerases as targets for the anticancer drug TAS- 103: DNA interactions and topoisomerase catalytic inhibition
    • Fortune JM, et al. (1999) DNA topoisomerases as targets for the anticancer drug TAS- 103: DNA interactions and topoisomerase catalytic inhibition. Biochemistry 38(47): 15580-15586.
    • (1999) Biochemistry , vol.38 , Issue.47 , pp. 15580-15586
    • Fortune, J.M.1
  • 50
    • 0032504157 scopus 로고    scopus 로고
    • Merbarone inhibits the catalytic activity of human topoisomerase IIa by blocking DNA cleavage
    • Fortune JM, Osheroff N (1998) Merbarone inhibits the catalytic activity of human topoisomerase IIa by blocking DNA cleavage. J Biol Chem 273(28): 17643-17650.
    • (1998) J Biol Chem , vol.273 , Issue.28 , pp. 17643-17650
    • Fortune, J.M.1    Osheroff, N.2
  • 51
    • 79953901930 scopus 로고    scopus 로고
    • Interactions between the etoposide derivative F14512 and human type II topoisomerases: Implications for the C4 spermine moiety in promoting enzyme-mediated DNA cleavage
    • Gentry AC, et al. (2011) Interactions between the etoposide derivative F14512 and human type II topoisomerases: Implications for the C4 spermine moiety in promoting enzyme-mediated DNA cleavage. Biochemistry 50(15): 3240-3249.
    • (2011) Biochemistry , vol.50 , Issue.15 , pp. 3240-3249
    • Gentry, A.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.